JD HEALTH's stock plummeted 5.00% during intraday trading on Friday, marking a significant pullback in the session.
The decline follows two consecutive sessions of gains totaling over 12% that were triggered by the company's strong first-quarter results and a major share buyback announcement. The recent rally appears to have prompted profit-taking among investors.
Additionally, the stock faced pressure from broad-based weakness across the Internet and Direct Marketing Retail sector, with several major peers also trading lower during the session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments